| Source HCPCS Code |
|
Target NDC Code |
J0153
|
⇄
|
00409-1932-01
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
|
⇄
|
00409-1932-02
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
|
⇄
|
00469-0871-20
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
|
⇄
|
00469-0871-30
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
00469-8234-12
ADENOCARD (ANSYR,LUER LOK) 3 MG/ML
|
| Detail Information |
| Relationship Start Date |
01/01/2015 |
| Relationship End Date |
12/01/2020 |
| Number Of Items In Ndc Package |
2 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SR |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
00469-8234-14
ADENOCARD (ANSYR,LUER LOK) 3 MG/ML
|
| Detail Information |
| Relationship Start Date |
1/1/2015 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
4 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SR |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
|
⇄
|
00641-6113-10
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
|
⇄
|
00703-8776-01
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
|
⇄
|
00703-8777-01
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
10019-0063-02
ADENOSINE (SDV,PF) 3 MG/ML
|
| Detail Information |
| Relationship Start Date |
1/1/2015 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
2 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
|
⇄
|
10019-0063-03
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
16714-0180-01
ADENOSINE (SDV,PF,LATEX-FREE) 3 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
02/19/2021 |
| Relationship End Date |
04/30/2023 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
16714-0556-01
ADENOSINE (PF,LATEX-FREE) 3 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
08/16/2022 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
|
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
16714-0972-01
ADENOSINE (SDV,PF,LATEX-FREE) 3 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
02/19/2021 |
| Relationship End Date |
04/30/2023 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
16714-0997-01
ADENOSINE (PF,LATEX-FREE) 3 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
08/16/2022 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
|
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
|
⇄
|
17478-0542-02
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
|
⇄
|
17478-0542-25
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
|
⇄
|
17478-0544-20
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
|
⇄
|
17478-0544-30
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
17478-0953-02
ADENOSINE NOVAPLUS (USP,SDV,PF,LATEX-FREE) 3 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
08/01/2018 |
| Relationship End Date |
01/27/2022 |
| Number Of Items In Ndc Package |
2 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
23155-0258-31
ADENOSINE (SDV,PF,LATEX-FREE) 3 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
08/02/2021 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
23155-0258-32
ADENOSINE (SDV,PF,LATEX-FREE) 3 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
08/02/2021 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
|
⇄
|
25021-0301-02
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
|
⇄
|
25021-0301-04
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
25021-0301-67
ADENOSINE (10X2ML,USP,PRF SYRINGE) 3 MG/ML
|
| Detail Information |
| Relationship Start Date |
01/01/2015 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
2 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SR |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
|
⇄
|
25021-0301-68
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
|
⇄
|
25021-0307-20
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
|
⇄
|
25021-0307-30
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
25021-0318-02
ADENOSINE (10X2ML,SDV,PF) 3 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
04/11/2023 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
2 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
25021-0318-04
ADENOSINE (10X4ML,SDV,PF) 3 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
04/11/2023 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
4 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
54569-5610-00
ADENOSINE (PF) 3 MG/ML
|
| Detail Information |
| Relationship Start Date |
1/1/2015 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
2 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
NA |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
54868-5551-00
ADENOSINE 3 MG/ML
|
| Detail Information |
| Relationship Start Date |
1/1/2015 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
2 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
55150-0192-01
ADENOSINE (SDV,PF,LATEX-FREE) 3 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
05/06/2020 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
55150-0192-20
ADENOSINE (SDV,PF,LATEX-FREE) 3 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
02/08/2018 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
55150-0193-01
ADENOSINE (SDV,PF,LATEX-FREE) 3 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
05/06/2020 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
55150-0193-30
ADENOSINE (SDV,PF,LATEX-FREE) 3 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
02/08/2018 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
55390-0067-10
ADENOSINE (S.D.V.,PF) 3 MG/ML
|
| Detail Information |
| Relationship Start Date |
1/1/2015 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
2 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
55390-0068-01
ADENOSINE (S.D.V.,PF) 3 MG/ML
|
| Detail Information |
| Relationship Start Date |
1/1/2015 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
4 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
63323-0651-02
ADENOSINE (PF) 3 MG/ML
|
| Detail Information |
| Relationship Start Date |
01/01/2015 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
2 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
63323-0651-04
ADENOSINE (PF) 3 MG/ML
|
| Detail Information |
| Relationship Start Date |
01/01/2015 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
4 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
63323-0651-20
ADENOSINE (SDV,PF,LATEX-FREE) 3 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
05/02/2018 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
63323-0651-30
ADENOSINE (SDV,PF,LATEX-FREE) 3 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
05/02/2018 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
63323-0651-89
SIMPLIST ADENOSINE (PF,LATEX-FREE) 3 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
03/11/2019 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
2 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SR |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
63323-0651-90
SIMPLIST ADENOSINE (PF,LATEX-FREE) 3 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
03/11/2019 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
4 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SR |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
67457-0854-04
ADENOSINE (10X4ML,SDV,PF) 3 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
05/08/2018 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
4 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
67457-0855-02
ADENOSINE (10X2ML,SDV,PF) 3 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
05/08/2018 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
2 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
67457-0856-20
ADENOSINE (1X20ML,USP,SDV,PF) 3 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
08/31/2017 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
67457-0857-30
ADENOSINE (1X30ML,USP,SDV,PF) 3 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
08/31/2017 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
67457-0858-20
ADENOSINE NOVAPLUS (USP;SDV,PF,LATEX-FREE) 3 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
04/15/2020 |
| Relationship End Date |
06/30/2025 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
67457-0859-30
ADENOSINE NOVAPLUS (USP,SDV,PF,LATEX-FREE) 3 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
09/01/2019 |
| Relationship End Date |
06/30/2025 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
71288-0207-21
ADENOSINE 10X20ML,SDV 3 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
06/09/2025 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
71288-0208-30
ADENOSINE SDV 3 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
06/09/2025 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)
|
⇄
|
72078-0033-02
ADENOSINE NOVAPLUS (SDV,PF,LATEX-FREE) 3 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
04/06/2022 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
2 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J0153
Adenosine inj 1mg
|
⇄
|
55150-0192-01
Adenosine
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
Adenosine inj 1mg
|
⇄
|
55150-0193-01
Adenosine
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
Adenosine inj 1mg
|
⇄
|
63323-0651-02
Adenosine
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
Adenosine inj 1mg
|
⇄
|
63323-0651-04
Adenosine
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
Adenosine inj 1mg
|
⇄
|
63323-0651-20
Adenosine
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
Adenosine inj 1mg
|
⇄
|
63323-0651-30
Adenosine
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
Adenosine inj 1mg
|
⇄
|
63323-0651-89
Adenosine
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
Adenosine inj 1mg
|
⇄
|
63323-0651-90
Adenosine
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
Adenosine inj 1mg
|
⇄
|
00404-9809-02
Adenosine
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
Adenosine inj 1mg
|
⇄
|
00404-9993-02
Adenosine
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
Adenosine inj 1mg
|
⇄
|
51662-1450-01
Adenosine
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
Adenosine inj 1mg
|
⇄
|
51662-1450-03
Adenosine
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
Adenosine inj 1mg
|
⇄
|
51662-1511-01
Adenosine
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
Adenosine inj 1mg
|
⇄
|
51662-1632-01
Adenosine
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
Adenosine inj 1mg
|
⇄
|
51662-1643-03
Adenosine
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
Adenosine inj 1mg
|
⇄
|
71288-0207-21
Adenosine
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
Adenosine inj 1mg
|
⇄
|
71288-0208-30
Adenosine
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
Adenosine inj 1mg
|
⇄
|
67457-0854-04
Adenosine
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
Adenosine inj 1mg
|
⇄
|
67457-0855-02
Adenosine
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
Adenosine inj 1mg
|
⇄
|
67457-0856-20
Adenosine
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
Adenosine inj 1mg
|
⇄
|
67457-0857-30
Adenosine
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
Adenosine inj 1mg
|
⇄
|
72078-0033-02
Adenosine
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
Adenosine inj 1mg
|
⇄
|
16714-0556-01
Adenosine
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
Adenosine inj 1mg
|
⇄
|
16714-0997-01
Adenosine
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
Adenosine inj 1mg
|
⇄
|
25021-0301-67
Adenosine
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
Adenosine inj 1mg
|
⇄
|
25021-0301-68
Adenosine
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
Adenosine inj 1mg
|
⇄
|
25021-0318-02
Adenosine
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J0153
Adenosine inj 1mg
|
⇄
|
25021-0318-04
Adenosine
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|